デフォルト表紙
市場調査レポート
商品コード
1728187

市販鎮痛剤市場-世界の産業規模、シェア、動向、機会、予測、薬剤タイプ別、流通チャネル別、地域別、競合別、2020年～2030年

Over-the-Counter Analgesics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type, By Distribution Channel, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 183 Pages
納期
2～3営業日
カスタマイズ可能
市販鎮痛剤市場-世界の産業規模、シェア、動向、機会、予測、薬剤タイプ別、流通チャネル別、地域別、競合別、2020年～2030年
出版日: 2025年05月16日
発行: TechSci Research
ページ情報: 英文 183 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

OTC鎮痛剤の世界市場は、2024年に210億5,000万米ドルと評価され、2030年までには351億2,000万米ドルに達すると予測され、予測期間中のCAGRは8.91%で成長します。

この成長は主に、セルフメディケーションに対する消費者の選好の高まり、疼痛管理に対する意識の高まり、慢性疼痛状態に陥りやすい高齢者人口の拡大によるものです。OTC鎮痛剤は、入手のしやすさ、費用対効果、利便性から広く使用されています。さらに、生活習慣に関連した障害や身体活動に関連した傷害の増加が、疼痛緩和ソリューションの需要を押し上げています。意識が高まり、安全なOTC薬の使用に対する規制当局の支援が拡大するにつれて、市場は世界各地域で継続的な発展を遂げる態勢が整っています。

市場概要
予測期間 2026年～2030年
市場規模：2024年 210億5,000万米ドル
市場規模：2030年 351億2,000万米ドル
CAGR：2025年～2030年 8.91%
急成長セグメント オンライン薬局
最大市場 北米

主要な市場促進要因

高齢化と慢性疾患の増加

主要な市場課題

規制強化と安全性への懸念

主要市場動向

個別化された疼痛緩和ソリューション

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の市販鎮痛剤市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 薬剤タイプ別（アセトアミノフェン、非ステロイド性抗炎症薬（NSAID）、サリチル酸塩およびその他の鎮痛剤）
    • 流通チャネル別（病院薬局、小売薬局、オンライン薬局）
    • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
    • 企業別（2024年）
  • 市場マップ
    • 薬剤タイプ別
    • 流通チャネル別
    • 地域別

第6章 北米の市販鎮痛剤市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の市販鎮痛剤市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋の市販鎮痛剤市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の市販鎮痛剤市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの市販鎮痛剤市場の展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品上市

第13章 世界の市販鎮痛剤市場：SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Johnson & Johnson Services Inc
  • GSK plc
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca Plc
  • Merck & Co Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 17073

The Global Over-the-Counter (OTC) Analgesics Market was valued at USD 21.05 billion in 2024 and is projected to reach USD 35.12 billion by 2030, growing at a CAGR of 8.91% during the forecast period. This growth is primarily attributed to increasing consumer preference for self-medication, rising awareness about pain management, and expanding geriatric population susceptible to chronic pain conditions. OTC analgesics are widely used due to their ease of availability, cost-effectiveness, and convenience. Moreover, lifestyle-related disorders and an increase in physical activity-related injuries are boosting the demand for pain relief solutions. As awareness grows and regulatory support for safe OTC use expands, the market is poised for continued advancement across global regions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 21.05 Billion
Market Size 2030USD 35.12 Billion
CAGR 2025-20308.91%
Fastest Growing SegmentOnline Pharmacies
Largest MarketNorth America

Key Market Drivers

Rising Aging Population and Chronic Conditions

The increasing elderly population and growing prevalence of chronic health issues are key contributors to the demand for OTC analgesics. Older adults often manage long-term conditions that cause recurring pain, leading to a consistent reliance on easily accessible medications. Many prefer OTC options over prescription drugs due to their convenience, affordability, and fewer regulatory hurdles. These conditions, including arthritis and back pain, span across age groups, expanding the target consumer base. Additionally, rising public awareness about chronic pain management encourages consumers to opt for OTC solutions that offer effective and quick relief without requiring a doctor's consultation.

Key Market Challenges

Regulatory Scrutiny and Safety Concerns

Strict regulatory oversight and ongoing safety evaluations present significant challenges for the OTC analgesics market. Authorities enforce stringent rules on ingredients, dosages, and interactions to ensure public safety, and any identified risks can lead to restrictions or product withdrawals. Adverse event reports or product recalls can harm brand trust and slow market momentum. Warning labels, age restrictions, and contraindications further narrow the target audience. These factors collectively create a cautious consumer environment, potentially curbing product usage and inhibiting market expansion.

Key Market Trends

Personalized Pain Relief Solutions

The demand for personalized OTC analgesics is gaining traction as consumers seek products tailored to their specific pain types, such as migraines or joint pain. This customization aligns with modern consumer expectations and improves user satisfaction and loyalty. By diversifying product offerings to address a broader range of conditions, companies can reach varied consumer segments. Innovation in formulation and delivery mechanisms not only sets brands apart but also drives sustained growth. Personalized solutions often lead to stronger consumer retention, reinforcing market strength through repeat purchases and brand advocacy.

Key Market Players

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Johnson & Johnson Services Inc
  • GSK plc
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca PLC
  • Merck & Co Inc.

Report Scope:

In this report, the Global Over-the-Counter (OTC) Analgesics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Over-the-Counter (OTC) Analgesics Market, By Drug Type:

  • Acetaminophen
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Salicylates
  • Other Analgesics

Over-the-Counter (OTC) Analgesics Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Over-the-Counter (OTC) Analgesics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Over-the-Counter (OTC) Analgesics Market.

Available Customizations:

Global Over-the-Counter (OTC) Analgesics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Over-the-Counter (OTC) Analgesics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)
    • 5.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
    • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.4. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Drug Type
    • 5.3.2. By Distribution Channel
    • 5.3.3. By Region

6. North America Over-the-Counter (OTC) Analgesics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Drug Type
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Over-the-Counter (OTC) Analgesics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Drug Type
        • 6.3.1.2.2. By Distribution Channel
    • 6.3.2. Canada Over-the-Counter (OTC) Analgesics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Drug Type
        • 6.3.2.2.2. By Distribution Channel
    • 6.3.3. Mexico Over-the-Counter (OTC) Analgesics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Drug Type
        • 6.3.3.2.2. By Distribution Channel

7. Europe Over-the-Counter (OTC) Analgesics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Drug Type
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. Germany Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Drug Type
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. United Kingdom Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Drug Type
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. Italy Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Drug Type
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. Spain Over-the-Counter (OTC) Analgesics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Drug Type
        • 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Over-the-Counter (OTC) Analgesics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Drug Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Drug Type
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. India Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Drug Type
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. Japan Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Drug Type
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. South Korea Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Drug Type
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. Australia Over-the-Counter (OTC) Analgesics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Drug Type
        • 8.3.5.2.2. By Distribution Channel

9. South America Over-the-Counter (OTC) Analgesics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Drug Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Over-the-Counter (OTC) Analgesics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Drug Type
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. Argentina Over-the-Counter (OTC) Analgesics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Drug Type
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. Colombia Over-the-Counter (OTC) Analgesics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Drug Type
        • 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Over-the-Counter (OTC) Analgesics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Drug Type
    • 10.2.2. By Distribution Channel
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Over-the-Counter (OTC) Analgesics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Drug Type
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Saudi Arabia Over-the-Counter (OTC) Analgesics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Type
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. UAE Over-the-Counter (OTC) Analgesics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Drug Type
        • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Over-the-Counter (OTC) Analgesics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Bayer AG
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Boehringer Ingelheim International GmbH
  • 15.3. Johnson & Johnson Services Inc
  • 15.4. GSK plc
  • 15.5. Pfizer Inc.
  • 15.6. Sanofi SA
  • 15.7. Sun Pharmaceutical Industries Ltd.
  • 15.8. Takeda Pharmaceutical Company Limited
  • 15.9. AstraZeneca Plc
  • 15.10. Merck & Co Inc.

16. Strategic Recommendations

17. About Us & Disclaimer